Access 105 Verified Employees Profiles for Naprod Life Sciences Pvt.Unlock Free Contacts Now
About
Neon Antibiotics Pvt. Ltd was started as a vision of Shri Babulal K. Jain in 1990 and was later renamed to Naprod Life Sciences Pvt. Ltd in 2006. Naprod Life Sciences Pvt. Ltd. has made rapid strides & now we are on the threshold of being a dominant player in Oncology space not only in India but across the globe.
Technical excellence & enthusiasm of Mr. Mohan B. Jain has been crucial in carrying forward the company vision to become a world class player in Onco through excellence in innovation, discovery of new manufacturing processes/drug delivery mechanisms & consistently high quality of production.
We are one of the pioneers in India in Lyophilization. Our ultra-modern manufacturing plant at Tarapur, Thane in Maharashtra State is equipped for production of generics & formulations of oncology & other therapeutic applications & meets the current GMP (Good Manufacturing Practices) norms as laid down by WHO. We have a robust marketing network across domestic & overseas operations. Our wide range of products are approved & recommended by numerous government, semi-government & privately run institutions. With a network across Indian sub-continent & market penetration in several countries across four continents, we are firmly on our way to meet our objective of reaching out to cancer patients worldwide. Our manufacturing plant is supported with four well equipped modern offices in Andheri, Mumbai.
OUR SPECIALITY:
o Anti-Cancer Formulations
o General Formulations
o Anesthetic Formulations
APPROVALS:
o INVIMA Facility approved
o ANVISA Facility approved
o PICS Facility approved
CERTIFICATIONS & AWARD:
o WHO Certified
o ISO 9001 : 2008 certified
o Dr. Reddy’s Business Partner Excellence Award 2016
o Best Employee Engagement Program of the Year 2017 for “Ummeed” by ACEF
RATING:
o CRISIL Rating: MSE*2 (Financial Strength High and Operating Performance High)
PATENTS:
o Naprod: A new semi - synthetic method of paclitaxel and docetaxel (patent number : 264627)